The Impact of Immunological Checkpoint Inhibitors and Targeted Therapy on Chronic Pruritus in Cancer Patients
Although pruritus may sometimes be a consequential situation to neoplasms, it more frequently emerges after commencing chemotherapy. In this review, we present our analysis of the chemotherapy treatments that most often induce skin changes and itching. After discussing conventional chemotherapies ca...
Main Authors: | Alessandro Allegra, Eleonora Di Salvo, Marco Casciaro, Caterina Musolino, Giovanni Pioggia, Sebastiano Gangemi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/1/2 |
Similar Items
-
Factors Affecting the Etiology of Intractable Pruritus in Hospitalized Patients Without Primary Skin Lesions
by: Neslihan Akdoğan, et al.
Published: (2019-05-01) -
Exploring factors associated with uremic pruritus
by: Chiu-Feng Wu, et al.
Published: (2022-01-01) -
Uremic Pruritus: From Diagnosis to Treatment
by: An-Yu Cheng, et al.
Published: (2022-04-01) -
Pruritus. Pathomechanism, management and novel treatment
by: Maciej Józefiak, et al.
Published: (2023-09-01) -
Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
by: Ping-Hsun Lu, et al.
Published: (2021-10-01)